dc.contributor.author | Greaves, Mike | |
dc.date.accessioned | 2014-10-01T09:20:04Z | |
dc.date.available | 2014-10-01T09:20:04Z | |
dc.date.issued | 2005-10-25 | |
dc.identifier | 377192 | |
dc.identifier | 3bdf703c-8fc9-4006-af09-7a5d496cff6d | |
dc.identifier | 27644541797 | |
dc.identifier.citation | Greaves , M 2005 , ' Pharmacogenetics in the management of coumarin anticoagulant therapy : the way forward or an expensive diversion? ' , PLoS Medicine , vol. 2 , no. 10 , e342 . https://doi.org/10.1371/journal.pmed.0020342 | en |
dc.identifier.issn | 1549-1277 | |
dc.identifier.other | aberdeen_publication: 9697 | |
dc.identifier.uri | http://hdl.handle.net/2164/3652 | |
dc.format.extent | 2 | |
dc.format.extent | 91387 | |
dc.language.iso | eng | |
dc.relation.ispartof | PLoS Medicine | en |
dc.subject | R Medicine | en |
dc.subject.lcc | R | en |
dc.title | Pharmacogenetics in the management of coumarin anticoagulant therapy : the way forward or an expensive diversion? | en |
dc.type | Journal item | en |
dc.contributor.institution | University of Aberdeen.Medicine, Medical Sciences & Nutrition | en |
dc.description.status | Peer reviewed | en |
dc.identifier.doi | 10.1371/journal.pmed.0020342 | |